Search

everythinglearnresearchcommunity

for

Search:↓

A 14-year-old girl with a condition that makes her hair easy to pull out also has a hair-pulling disorder, and treatment helped but she relapsed after a year.

NFATc1 controls hair stem cell activity, affecting hair growth and could be a target for hair loss treatments.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

The combination therapy was effective and well-tolerated, especially in young patients.

TA-Ado effectively promotes hair growth and reduces hair loss.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

Some cancer treatments can cause abnormal fine hair growth.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

High glycine–tyrosine keratin-associated proteins help make hair strong and maintain its shape.

A gene mutation in Lama3 is linked to a common type of hair loss.

A WNT10A gene mutation leads to ectodermal dysplasia by disrupting cell growth and differentiation.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

A new mutation in the mitochondrial DNA was found in a boy with MELAS, even though his family didn't show typical signs.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Removing β-catenin in certain stem cells causes hair whitening and pigmentation issues.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

KRTAP10 proteins help form the hair shaft's tough outer layer by interacting with specific hair keratins.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The lentiviral array can monitor and predict gene activity during stem cell differentiation.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Generative AI tools like GPT-4o can effectively automate SALT scoring for alopecia areata, matching clinician accuracy.

Early treatment of traction alopecia can reverse hair loss; prevention involves avoiding tight hairstyles.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.